Targeted therapies and outcomes data: the inflammatory hypothesis matures.
Publication
, Journal Article
Sharan, L; Krasuski, RA
Published in: Curr Opin Lipidol
February 2018
Duke Scholars
Published In
Curr Opin Lipidol
DOI
EISSN
1473-6535
Publication Date
February 2018
Volume
29
Issue
1
Start / End Page
56 / 57
Location
England
Related Subject Headings
- Prognosis
- Molecular Targeted Therapy
- Inflammation Mediators
- Inflammation
- Humans
- Cardiovascular System & Hematology
- Cardiovascular Diseases
- Anti-Inflammatory Agents
- 3205 Medical biochemistry and metabolomics
- 3201 Cardiovascular medicine and haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Sharan, L., & Krasuski, R. A. (2018). Targeted therapies and outcomes data: the inflammatory hypothesis matures. Curr Opin Lipidol, 29(1), 56–57. https://doi.org/10.1097/MOL.0000000000000477
Sharan, Lauren, and Richard A. Krasuski. “Targeted therapies and outcomes data: the inflammatory hypothesis matures.” Curr Opin Lipidol 29, no. 1 (February 2018): 56–57. https://doi.org/10.1097/MOL.0000000000000477.
Sharan L, Krasuski RA. Targeted therapies and outcomes data: the inflammatory hypothesis matures. Curr Opin Lipidol. 2018 Feb;29(1):56–7.
Sharan, Lauren, and Richard A. Krasuski. “Targeted therapies and outcomes data: the inflammatory hypothesis matures.” Curr Opin Lipidol, vol. 29, no. 1, Feb. 2018, pp. 56–57. Pubmed, doi:10.1097/MOL.0000000000000477.
Sharan L, Krasuski RA. Targeted therapies and outcomes data: the inflammatory hypothesis matures. Curr Opin Lipidol. 2018 Feb;29(1):56–57.
Published In
Curr Opin Lipidol
DOI
EISSN
1473-6535
Publication Date
February 2018
Volume
29
Issue
1
Start / End Page
56 / 57
Location
England
Related Subject Headings
- Prognosis
- Molecular Targeted Therapy
- Inflammation Mediators
- Inflammation
- Humans
- Cardiovascular System & Hematology
- Cardiovascular Diseases
- Anti-Inflammatory Agents
- 3205 Medical biochemistry and metabolomics
- 3201 Cardiovascular medicine and haematology